This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Is Nuveen ESG MidCap Growth ETF (NUMG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for NUMG
Agilent (A) to Penetrate Chromatography Market Via New Tie-Up
by Zacks Equity Research
Agilent (A) collaborates with Mettler Toledo to lessen errors during sample preparation for achieving better chromatographic results.
Why Mettler-Toledo (MTD) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Mettler-Toledo (MTD) Q2 Earnings & Sales Beat, Increase Y/Y
by Zacks Equity Research
Mettler-Toledo's (MTD) second-quarter 2022 results benefit from robust Laboratory and Industrial segments, and solid momentum across the Americas and Asia.
Mettler-Toledo (MTD) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 7.56% and 3.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Mettler-Toledo's (MTD) Q2 Earnings?
by Zacks Equity Research
Mettler-Toledo's (MTD) Q2 results are likely to reflect the benefits of a robust product portfolio and comprehensive services. However, supply-chain constraints might have been a concern.
Bruker (BRKR) Earnings Expected to Grow: What to Know Ahead of Q2 Release
by Zacks Equity Research
Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mettler-Toledo (MTD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Nuveen ESG MidCap Growth ETF (NUMG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for NUMG
Zacks Industry Outlook Highlights Mettler-Toledo International, Waters and Bruker
by Zacks Equity Research
Mettler-Toledo International, Waters and Bruker have been highlighted in this Industry Outlook article.
3 Stocks to Watch on Rising Demand for Scientific Instruments
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), Waters (WAT) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand, as well as rising healthcare spending.
Is Nuveen ESG MidCap Growth ETF (NUMG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for NUMG
Mettler-Toledo (MTD) Q1 Earnings & Sales Beat, Increase Y/Y
by Zacks Equity Research
Mettler-Toledo's (MTD) first-quarter 2022 results benefit from robust Laboratory and Industrial segments, and solid momentum across geographical regions.
Mettler-Toledo (MTD) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 7.51% and 3.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Bruker (BRKR) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Bruker (BRKR) delivered earnings and revenue surprises of 19.51% and 3.90%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Mettler-Toledo's (MTD) Q1 Earnings?
by Zacks Equity Research
Mettler-Toledo's (MTD) Q1 results are likely to reflect the benefits of a robust product portfolio and comprehensive services. Yet, supply-chain constraints might have been headwinds.
Mettler-Toledo (MTD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Looking for a Growth Stock? 3 Reasons Why Mettler-Toledo (MTD) is a Solid Choice
by Zacks Equity Research
Mettler-Toledo (MTD) possesses solid growth attributes, which could help it handily outperform the market.
Here is Why Growth Investors Should Buy Mettler-Toledo (MTD) Now
by Zacks Equity Research
Mettler-Toledo (MTD) could produce exceptional returns because of its solid growth attributes.
Zacks Industry Outlook Highlights: Mettler-Toledo International and Bruker
by Zacks Equity Research
Mettler-Toledo International and Bruker are highlighted in this Industry Outlook article.
2 Stocks to Buy on Rising Demand for Scientific Instruments
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand as well as rising healthcare spending.
Is Mettler-Toledo (MTD) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Mettler-Toledo (MTD) could produce exceptional returns because of its solid growth attributes.
Mettler-Toledo (MTD) Q4 Earnings & Sales Beat, Increase Y/Y
by Zacks Equity Research
Mettler-Toledo's (MTD) fourth-quarter 2021 results benefit from robust Laboratory and Industrial segments.
Mettler-Toledo (MTD) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Mettler-Toledo (MTD) delivered earnings and revenue surprises of 4.57% and 1.70%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
What's in the Offing for Mettler-Toledo's (MTD) Q4 Earnings?
by Zacks Equity Research
Mettler-Toledo's (MTD) fourth-quarter results are likely to reflect benefits of strong momentum across the laboratory and industrial businesses amid the coronavirus-induced headwinds.